India Genetic Testing Market Outlook to 2028

India Genetic Testing Market Overview

The India Genetic Testing Market was valued at USD 114 million in 2023, driven by the increasing prevalence of genetic disorders, rising awareness about personalized medicine, and advancements in technology. The market is segmented into predictive testing, carrier testing, prenatal testing, and pharmacogenetic testing, with predictive testing being the most dominant due to its role in early detection and prevention.

Major players in the India Genetic Testing Market include Strand Life Sciences, Med Genome, Mapmygenome, DNA Labs India, and Xcode Life. These companies are recognized for their advanced genetic testing services and their emphasis on personalized healthcare solutions. Strand Life Sciences leads the market with its comprehensive range of genomic services and collaborations with hospitals across India.

In Northern India, cities like Delhi, Mumbai, and Bengaluru dominate the market due to their advanced healthcare infrastructure and increasing awareness about genetic disorders. These regions are characterized by a growing demand for predictive and prenatal testing.

In 2023, Med Genome launched a new panel for genetic testing focused on hereditary cancer screening, aimed at individuals with a family history of cancer. This innovation reflects the growing emphasis on personalized medicine and the increasing demand for preventive healthcare solutions in India.

India Genetic Testing Market Segmentation

The India Genetic Testing Market can be segmented by test type, end-user, and region:

By Test Type: The market is segmented into predictive testing, carrier testing, prenatal testing, and pharmacogenetic testing. In 2023, predictive testing remains the most dominant test type due to its ability to identify potential genetic risks early. Prenatal testing is also gaining traction, especially among high-risk pregnancies, due to its non-invasive nature and accuracy.

By End-User: The market is segmented by end-users into hospitals, diagnostic laboratories, and research institutions. In 2023, hospitals dominate the market due to their extensive reach and partnerships with genetic testing providers. Diagnostic laboratories are rapidly growing in market share, driven by advancements in testing technologies and collaborations with healthcare providers.

By Region: The India market is segmented regionally into North, South, East, and West. In 2023, Northern India leads the market due to its advanced healthcare infrastructure and growing awareness of genetic testing. Southern India is also a significant market, driven by medical tourism and the increasing adoption of personalized medicine.

India Genetic Testing Market Competitive Landscape

Company

Establishment Year

Headquarters

Strand Life Sciences

2000

Bengaluru, India

Med Genome

2013

Bengaluru, India

Mapmygenome

2013

Hyderabad, India

DNA Labs India

2015

Nashik, India

Xcode Life

2011

Chennai, India

Strand Life Sciences: In 2023, Strand Life Sciences expanded its genomic testing services to include a comprehensive range of tests for hereditary cancer syndromes. This expansion is aimed at addressing the growing demand for personalized cancer screening in India.

Med Genome: In 2024, Med Genome launched a new range of pharmacogenetic tests designed to personalize medication plans for patients based on their genetic makeup. This expansion reflects the company's commitment to advancing personalized medicine in India.

India Genetic Testing Market Analysis

Market Growth Drivers:

Rising Prevalence of Genetic Disorders: In India, over 70 million people are estimated to suffer from genetic disorders, such as thalassemia, sickle cell anemia, and various hereditary cancers, driving the demand for genetic testing services to enable early detection and personalized treatment plans.

Technological Advancements in Genetic Testing: The cost of next-generation sequencing (NGS) has dropped over the past decade, making advanced genetic testing more accessible to a larger population. Additionally, the number of diagnostic labs offering NGS has increased to more than 150 across the country, boosting market penetration.

Growing Adoption of Personalized Medicine: An estimated 1.5 million genetic tests were conducted in India in 2022, reflecting the growing focus on personalized healthcare solutions. As more healthcare providers adopt genetic testing to tailor treatments, the market is witnessing increased demand from hospitals and diagnostic centers across the country.

Market Challenges
:

Limited Genetic Counseling Services: The availability of qualified genetic counselors in India remains limited, which can hinder the proper interpretation of genetic test results for patients. Without expert guidance, patients may struggle to understand the implications of their genetic data, leading to underutilization of genetic testing services.

Privacy and Ethical Concerns: The increasing use of genetic data raises concerns about data privacy and the potential misuse of sensitive personal information. Ensuring secure handling of genetic data and addressing ethical concerns around data sharing and genetic discrimination are significant challenges for the market.

Low Awareness in Rural Areas: While genetic testing awareness is increasing in urban regions, rural areas in India still face a lack of understanding about the benefits and availability of genetic testing. This gap limits the potential market reach and adoption of genetic testing services across the country.

Government Initiatives:

National Guidelines for Genetic Testing: In 2022, the Indian Council of Medical Research (ICMR) indeed introduced comprehensive guidelines for genetic testing aimed at regulating the market and ensuring quality control. These guidelines encompass over 700 genetic disorders, establishing a regulatory framework for testing practices and promoting ethical standards across laboratories. The guidelines were developed to address the growing need for stringent regulations in the field of genetic testing, particularly as the market for genetic tests expands.

Rare Disease Research Program: The Indian government's National Policy for Rare Diseases, implemented in 2021, will have financial support of up to Rs. 20 lakhs, those suffering from rare diseases listed under Group 1 (disorders amenable to one-time curative treatment) under the Rashtriya Arogya Nidhi scheme.

India Genetic Testing Market Future Market Outlook

The India Genetic Testing Market is expected to continue its rapid growth, driven by increased adoption of personalized medicine, advancements in technology, and rising healthcare awareness.

Future Market Trends:

Growth of Direct-to-Consumer (DTC) Genetic Testing Services: Direct-to-consumer genetic testing services, where individuals can order and access genetic tests without a physician referral, are expected to gain popularity. This model offers convenience, empowering consumers to take a proactive role in managing their health and genetic predispositions.

Increased Focus on Preventive Healthcare: There will likely be a growing emphasis on genetic tests designed for preventive healthcare, enabling individuals to assess their risk for conditions such as cancer, cardiovascular diseases, and diabetes. Advances in early detection and screening technologies will drive the adoption of these services.

Integration of AI and Big Data in Genetic Testing: The integration of artificial intelligence (AI) and big data analytics in genetic testing is anticipated to revolutionize the industry by providing faster, more accurate test results. These technologies will help in decoding complex genetic data and offering personalized treatment recommendations, enhancing overall patient outcomes.
Please Note: It will take 5-7 business days to complete the report upon order confirmation